Firm seeks NIH grant to conduct study of epilepsy Dx tool

04/30/2013 | MedCityNews.com

A pair of doctors who founded Cognizance Biomarkers are working on a blood-based test to detect epilepsy more precisely and reduce overdiagnosis of the condition. The firm is applying for NIH funding to conduct a proof of principle study for the assay, which is intended to locate an anti-inflammatory protein originating from the brain that is often found in low concentrations in epilepsy patients.

View Full Article in:

MedCityNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC